Search results
Psychedelics Stocks Are Falling After a Shocking Vote at the FDA. Here's What You Need to Know.
Motley Fool via Yahoo Finance· 3 days agoIf you're not familiar, MDMA is known by the street names...
Could Magic Mushrooms Be a Surprising Remedy for Long Covid?
The New York Sun· 7 days agoIn an intriguing development, researchers are exploring the potential of psychedelics as a treatment...
FDA issues warning against 'microdosing' chocolate bars that sent 6 to the hospital
INSIDER via Yahoo News· 4 days agoIt's become trendy in Silicon Valley. And some CEOs say they've added microdosing to their morning...
Should You Buy the Dip on Compass Pathways Stock? | The Motley Fool
The Motley Fool· 1 day agoOn that note, Compass Pathways (CMPS 7.04%) stock fell by 9% on June 4, and the stock is down 20%...
Dutch experts take different view of ecstasy
Politico· 7 days agoAmericans with PTSD probably won’t be able to legally get the psychedelic drug MDMA — better known as ecstasy — to treat their condition after a Food and Drug Administration ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 6 days agoNuminus Wellness Comments on FDA Advisory Committee Meeting for Investigational MDMA-Assisted Therapy for PTSD PR Newswire VANCOUVER, BC, June 7, 2024 VANCOUVER, BC, June ...
Santa Rosa: Man accused of targeting juveniles for drug sales
San Jose Mercury News· 5 days agoA 32-year-old Cotati man used social media applications like Instagram and took payments through...
Psilocybin Therapy Pilot Program Bill Introduced in California
High Times· 4 hours agoA psilocybin treatment bill was recently introduced on June 6 by California Sen. Brian W. Jones and Sen. Josh Becker, which if passed would create a pilot program for psilocybin therapy. Senate ...
The meat workers who became vegan entrepreneurs
BBC News· 1 day agoIn 2016, Andy Shovel was feeling rudderless. The pair realised that this was a growth industry where they could put their food industry experience to...
Some psychedelic medicine developers want to ditch the therapy aspect. What could go wrong?
Salon.com· 6 days agoBack in 2016, Rosalind Watts volunteered to work on one of Imperial College London’s early trials...